Research And Markets Research And Markets
0 CHECKOUT

Belarus Pharmaceuticals and Healthcare Report Q2 2016

  • ID: 3616018
  • February 2016
  • Region: Belarus
  • 75 pages
  • Business Monitor International
1 of 3

Government initiatives to boost the nascent domestic pharmaceutical industry and reduce the reliance on imports will limit the attractiveness of Belarus to multinational drugmakers. Government interference, in the form of domestic bias in the medicine tendering process and pricing controls, will further reduce revenue earning opportunities. Additional risks include a continued poor economic forecast and rising regional geopolitical tensions.

Headline Expenditure Projections

Pharmaceuticals: BYR12,247bn in 2015 (USD801mn) to BYR14,219bn (USD783mn) in 2016; +16.1% in local currency terms and -2.1% in US dollar terms.

Healthcare: BYR60,885bn (USD3.98bn) in 2015 to BYR71,906bn (USD3.96bn) in 2016; +18.1% in local currency terms and -0.4% in US dollar terms.

Note: Product cover images may vary from those shown
2 of 3

Industry View
Table: Headline PharmaceuticalsHealthcare Forecasts (Belarus 2014-2020)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2012-2020)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2014-2020)

Industry Risk Reward Index

Central And Eastern Europe Risk/Reward Index

Belarus Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing And Reimbursement Regime

Market Overview

Healthcare Sector
Table: Healthcare Resources (Belarus 2010-2015)
Table: Healthcare Personnel (Belarus 2010-2015)
Table: Healthcare Activity (Belarus 2010-2015)

Research And Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Multinational Market Activity

Generic Drugmakers

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

Lekpharm

Demographic Forecast

Demographic Outlook
Table: Population Headline Indicators (Belarus 1990-2025)
Table: Key Population Ratios (Belarus 1990-2025)
Table: Urban/Rural PopulationLife Expectancy (Belarus 1990-2025)
Table: Population By Age Group (Belarus 1990-2025)
Table: Population By Age Group(Belarus 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db